Stay updated with breaking news from David Lebowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Citi initiated coverage on BridgeBio Pharma Inc BBIO, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, noting an…
Citi initiated coverage on BridgeBio Pharma Inc (NASDAQ: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, noting an optimistic outlook on the stock.
The group votes to send a letter to UC San Diego and the California Coastal Commission opposing continued tight restrictions on public access that began with the COVID-19 pandemic.
Letters to the editor
Letters to the editor